The first Biogen trade was made in Q4 2015.
Since then First Eagle Investments bought shares four more times and sold shares on three occasions. The investor sold all their shares in Q3 2020 and doesn't own any shares in Biogen anymore.
Avg closing price
Price range
Sold -57.3 Thousand shares
Q3 2020
Avg closing price
$278.91
Price range
$264.77
-
$305.71
New holding (+57.3 Thousand shares)
Q2 2020
Avg closing price
$300.59
Price range
$258.66
-
$342.55
Sold -257 Thousand shares
Q1 2017
Avg closing price
$275.09
Price range
$251.52
-
$297.85
Sold 43.8% shares (-200 Thousand shares)
Q4 2016
Avg closing price
$272.86
Price range
$251.75
-
$298.61
Increased shares by 37.4% (+125 Thousand shares)
Q3 2016
Avg closing price
$272.63
Price range
$222.79
-
$303.87
Increased shares by 48.2% (+108 Thousand shares)
Q2 2016
Avg closing price
$242.59
Price range
$206.74
-
$267.16
Increased shares by 15.8% (+30.7 Thousand shares)
Q1 2016